Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebivolol Added to Existing Antihypertensive Treatment in Mild to Moderate Hypertension
NCT00200434Phase 3Completed
- Sponsor
- Viatris
- Start
- Oct 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of nebivolol in hypertension (HTN) (4 arms), sponsored by Viatris. Primary endpoint: Change from baseline in average sitting diastolic blood pressure at trough at 12 weeks. Started Oct 2002; status: completed.
02
Drugs
nebivolol
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00200434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00200434.